Stocks Health care NTRB
NASDAQ · Health careNutriBand Inc. (NTRB)
NutriBand Inc. brought in $1.6M of revenue over the twelve months to July 31, 2026, down 37.3% from a year earlier. It posted a net loss of $7M. In fiscal 2026 capital spending exceeded operating cash flow by $5.1M. At July 31, 2026 it held $3.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 4, 2026.
Key facts about NutriBand Inc.
- Net worth
- NutriBand Inc. has a market value (market cap) of $70M at the latest share price, and shareholders' equity of $5.3M on its balance sheet at July 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $2M (-4.8% year on year), with a net loss of $8.2M. Over the 12 months to July 31, 2026: revenue $1.6M, net loss $7M.
- Cash flow
- In fiscal 2026 operations used $5.1M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on September 4, 2026 and covers the period to July 31, 2026. Open on SEC EDGAR
- Next earnings report
- NutriBand Inc.'s next report is expected around December 10, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What NutriBand Inc. does
NutriBand Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker NTRB.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $2M | -$8.2M | -$2.58 | -$5.1M |
| 2025 | $2.1M | -$10.5M | -$0.99 | -$4.7M |
| 2024 | $2.1M | -$5.5M | -$0.69 | -$3.6M |
| 2023 | $2.1M | -$4.5M | -$0.53 | -$3.1M |
| 2022 | $1.4M | -$6.2M | -$0.80 | -$2.9M |
| 2021 | $943.7K | -$2.9M | -$0.51 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where NTRB ranks in Health care
Latest SEC filings
What NutriBand Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 30, 2026Delisting notice 25-NSE
- September 23, 2026
- September 15, 2026Activist stake changed SCHEDULE 13D/A
- September 4, 2026Quarterly report 10-Q · period to July 31, 2026Revenue fell 30% to $437.5K versus the same quarter last year; diluted EPS -$0.07 versus -$2.12.
- June 22, 2026
- June 11, 2026Quarterly report 10-Q · period to April 30, 2026Revenue fell 35% to $433.4K versus the same quarter last year; diluted EPS -$0.10 versus -$0.12.
- May 18, 2026Annual report (amended) 10-K/A · period to January 31, 2026Revenue fell 4.8% to $2M versus the prior year; diluted EPS -$2.58 versus -$0.99.
- April 29, 2026Annual report 10-K · period to January 31, 2026Revenue fell 4.8% to $2M versus the prior year; diluted EPS -$2.58 versus -$0.99.
- April 7, 2026
- February 13, 2026
Insider trades
What the people running NutriBand Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns NTRB
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vitale Botgros13D, may seek influence with 1 related filers | 32.37% | September 19, 2024 |
| T.I.I. - Jetservices, Lda13D, may seek influence | 15.92% | January 23, 2024 |
| Gareth Sheridan13D, may seek influence | 14.2% | September 15, 2026 |
| Serguei Melnik13D, may seek influence | 9.39% | March 13, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 16 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Vanguard Capital Management LLC | 174,927 | 0 |
| Geode Capital Management, LLC | 62,494 | -7,559 |
| Vanguard Fiduciary Trust Co | 25,111 | 0 |
| State Street Corp | 24,966 | 0 |
| Citadel Advisors LLC | 18,996 | new |
| Northern Trust Corp | 11,570 | -2,375 |
| Haven Private, LLC | 11,366 | 0 |
| BlackRock, Inc. | 10,662 | +1,121 |
| Osaic Holdings, Inc. | 3,684 | -1,167 |
| Vanguard Global Advisers, LLC | 2,700 | 0 |
| Wells Fargo & Company | 2,600 | 0 |
| Tower Research Capital LLC (TRC) | 2,107 | +1,077 |
| UBS Group AG | 672 | -31,992 |
| Jones Financial Companies Lllp | 466 | 0 |
| Barclays PLC | 19 | new |
| Harbour Investments, Inc. | 3 | 0 |
Insiders
Questions about NTRB
What does NutriBand Inc. do?
NutriBand Inc. is a company in the Health care sector, listed on NASDAQ as NTRB. Its shares trade on NASDAQ under the ticker NTRB.
What is NutriBand Inc.'s net worth?
NutriBand Inc. has a market value (market cap) of $70M at the latest share price, and shareholders' equity of $5.3M on its balance sheet at July 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is NutriBand Inc. profitable?
No. Over the twelve months to July 31, 2026 it reported a net loss of $7M on revenue of $1.6M.
How much revenue does NutriBand Inc. make?
Over the twelve months to July 31, 2026 NutriBand Inc. reported revenue of $1.6M. That is 37.3% less than a year earlier.
When did NutriBand Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 4, 2026. It covers the period to July 31, 2026. Its newest filing of any kind is the delisting notice from September 30, 2026.
When is NutriBand Inc.'s next earnings report?
NutriBand Inc.'s next report is expected around December 10, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare NTRB with
Follow NTRB
Get an email when NutriBand Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values NutriBand Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.